COST EFFECTIVENESS OF ADDING EZETIMIBE TO ATORVASTATIN THERAPY IN PATIENTS NOT AT LDL CHOLESTEROL TREATMENT GOAL IN BRAZIL

被引：0
|
作者：
Araujo, G. T. [1 ]
Fonseca, M. [1 ]
Etto, H. [2 ]
Davies, G. M. [3 ]
Hsu, T. Y. [4 ]
机构：
[1] Univ Fed Sao Paulo, Axia Bio Consulting, Sao Paulo, Brazil
[2] Axia Bio, Sao Paulo, Brazil
[3] Merck & Co Inc, Upper Gwynedd, PA USA
[4] Merck Sharp & Dohme Ltd, Whitehouse Stn, NJ USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.999
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A372 / A372
页数：1
相关论文
共 50 条
  • [1] Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada
    Michele Kohli
    Cheryl Attard
    Annette Lam
    Daniel Huse
    John Cook
    Chantal Bourgault
    Evo Alemao
    Donald Yin
    Michael Marentette
    [J]. PharmacoEconomics, 2006, 24 : 815 - 830
  • [2] Cost effectiveness of adding ezetimibe to atorvastatin therapy in patients not at cholesterol treatment goal in Canada
    Kohli, Michele
    Attard, Cheryl
    Lam, Annette
    Huse, Daniel
    Cook, John
    Bourgault, Chantal
    Alemao, Evo
    Yin, Donald
    Marentette, Michael
    [J]. PHARMACOECONOMICS, 2006, 24 (08) : 815 - 830
  • [3] COST-EFFECTIVENESS OF ADDING EZETIMIBE TO ATORVASTATIN THERAPY IN PORTUGAL
    Laires, P.
    Tun-Ying, H.
    Ambegaonkar, B. M.
    Davies, G. M.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A371 - A371
  • [4] Cost-effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal
    Laires, Pedro A.
    Ejzykowicz, Flavia
    Hsu, Tun-Ying
    Ambegaonkar, Baishali
    Davies, Glenn
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (08) : 565 - 572
  • [5] Cost effectiveness of atorvastatin (Lipitor) as single therapy and dual therapy with ezetimibe (Zetia)
    Bui, T
    Harrison, DL
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 268 - 268
  • [6] The cost-effectiveness of atorvastatin, rosuvastatin and simvastatin in treating patients to LDL-cholesterol targets
    Niskanen, L.
    Peura, P. K.
    Hallinen, T.
    Soini, E.
    Martikainen, J.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 860 - 860
  • [7] The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients
    Mikhailidis, Dimitri P.
    Lawson, Richard W.
    McCormick, Anna-Louise
    Sibbring, Gillian C.
    Tershakovec, Andrew M.
    Davies, Glenn M.
    Tunceli, Kaan
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1961 - 1961
  • [8] The cost effectiveness of ezetimibe in CHD and CHD equivalent patients not at total cholesterol goal on statin monotherapy in Scotland
    Cook, JR
    Yin, DD
    Alemao, EA
    Drummond, MF
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 332 - 332
  • [9] EVALUATION OF EFFECTIVENESS OF THE COMBINED TREATMENT WITH ATORVASTATIN AND EZETIMIBE IN PATIENTS WITH CHD
    Kapanadze, K.
    Kipshidze, N.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 190 - 190
  • [10] Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy
    Gonzalez, Carlos A.
    Rubio-Guerra, Alberto F.
    Pavia, Abel
    Redding, Francisco J.
    Cervantes, Jose L.
    Zacarias, Jose L.
    Yza, Ruben
    Carranza, Jaime
    Fernandez, Pedro
    Morales, Enrique
    Robles, Francisco J.
    Leyva, Jose L.
    Rodriguez, Leticia
    [J]. CLINICAL DRUG INVESTIGATION, 2007, 27 (05) : 333 - 337
12345